Gennex Lab Peer Comparison

BSE: 531739

₹9.28

₹-0.15 (-1.59%)

As on 15-Oct-2026IST

Market cap

₹225 Cr

Revenue (TTM)

₹183 Cr

P/E Ratio

11.6

P/B Ratio

1

Div. Yield

0 %

Edit

	Gennex Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	225	18,056	17,506	17,424	15,984
Revenue (₹ Cr)	183	1,682	2,287	2,570	3,230
Net Profit (₹ Cr)	20.63	273.51	678.07	735.15	666.92
Net Margin (%)	11.07	16.19	28.10	26.88	20.60
RoE (%)	9.14	11.15	19.73	19.16	18.75
Price to Earnings	11.63	60.73	26.31	23.70	24.82
Price-To-Book	0.99	6.72	4.77	3.95	3.96

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Gennex Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Operating Revenue	183.06	1,682.47	2,287.33	2,569.77	3,229.67
Total Income	186.38	1,689.83	2,413.29	2,735.39	3,237.12
Total Expenditure	156.66	1,203.91	1,490.75	1,628.14	2,090.06
EBITDA	26.39	478.55	796.58	941.63	1,139.61
Depreciation	2.71	126.01	78.10	57.58	281.06
EBIT	23.68	352.55	718.48	884.05	858.55
Interest	4.12	52.11	0.88	7.69	190.64
Other Income	3.33	7.37	125.96	165.62	7.45
Exceptional Items	-0.60	12.16	0.00	-49.16	-17.24
Profit before Tax	22.29	319.96	843.56	992.82	658.12
Provision for Tax	1.66	46.45	165.49	257.67	-8.80
Profit after Tax	20.63	273.51	678.07	735.15	666.92

Liabilities (₹ Cr)

	Gennex Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Shareholder's Funds	222.52	2,591.20	3,586.42	4,202.90	3,902.67
Minority Interest	-1.23	0.00	-12.71	0.00	-21.81
Non-Current Liabilities	43.44	266.35	28.74	91.50	1,392.75
Current Liabilities	72.40	848.06	385.94	627.48	2,077.10
Total Liabilities	256.04	3,310.68	3,207.85	4,911.11	6,865.52

Assets (₹ Cr)

	Gennex Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Non-Current Assets	74.07	2,525.44	1,291.22	770.28	5,617.77
Current Assets	264.66	1,109.77	2,585.66	3,803.22	1,539.85
Total Assets	256.04	3,310.68	3,207.85	4,911.11	6,865.52
Total Debt*	24.28	586.37	0.55	2.50	2,421.66
Net Current Assets	192.26	261.71	2,199.72	3,175.74	-537.25
Contingent Liabilities	0.98	76.22	0.64	363.79	51.96

Cashflow (₹ Cr)

	Gennex Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Cash From Operating Activities	-10.80	132.27	432.37	659.75	1,065.01
Cash Flow from Investing Activities	0.82	-199.13	-334.73	-71.34	-79.97
Cash from Financing Activities	4.57	62.65	-38.32	-205.34	-881.32
Net Cash Inflow / Outflow	-5.41	-4.21	59.32	383.07	103.72

Ratios

Profitability Ratios

	Gennex Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
ROCE (%)	12.49	6.95	26.22	26.21	13.59
ROE (%)	9.14	11.15	19.73	19.16	18.75
ROA (%)	6.82	7.80	18.69	14.95	9.26
EBIT Margin (%)	12.94	20.95	31.41	34.40	26.58
Net Margin (%)	11.07	16.19	28.10	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Gennex Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Revenue Growth (%)	23.78	27.91	15.01	10.69	9.59
EBIT Growth (%)	18.82	58.32	18.45	24.14	16.84
Net Profit Growth (%)	11.37	149.56	19.61	-9.09	62.68
EPS Growth (%)	6.03	-3.57	17.73	14.40	67.41
Book Value Growth (%)	9.90	30.63	23.77	17.30	10.19

Valuation Ratios

	Gennex Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Price / Earnings	11.28	64.42	26.31	22.59	24.03
Price / Book Value	0.99	6.72	4.77	3.95	3.94
Dividend Yield (%)	0.00	0.07	0.35	1.97	0.00
EV/EBITDA	7.33	39.01	20.71	15.20	15.89
Market Cap (₹ Cr)	274.07	6,484.12	15,219.80	18,318.10	19,292.77

Solvency Ratios

	Gennex Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debt to Equity	0.00	0.07	0.00	0.00	0.24
Short term debt to equity ratio	0.05	0.13	0.00	0.00	0.14
Current Ratio	3.66	1.31	6.70	6.06	0.74
Quick Ratio	2.91	0.88	5.59	5.31	0.53
Interest Coverage	6.41	7.14	959.59	130.11	4.45

Operating Efficiency Ratios

	Gennex Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debtors to sales (%)	23.79	30.84	36.10	7.07	21.07
Asset Turnover	0.61	0.48	0.63	0.52	0.45
Receivable days	37.35	118.15	110.70	29.10	54.06
Inventory Days	71.39	98.29	65.86	69.53	32.16
Payable days	53.27	128.16	105.88	76.77	140.91
Cash Conversion Cycle	55.46	88.28	70.68	21.86	-54.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.